Baxter acquiring gene-therapy firm

Almost a week after announcing Baxter was going to break into two divisions, the Illinois company is already expanding.

Crain's Chicago Business reports that the company is buying up partner Chatham Therapeutics for $70 million.

Crain's notes that the $70-million deal may not be an all-in-one payment and that Baxter may provide the gene therapy company milestone payments even after the purchase.

You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.